Cerebrospinal fluid phospho-tau T217 outperforms T181 as a...

Alzheimer's Research & Therapy 2020 / 12 Vol. 12; Iss. 1

Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer’s disease and PET amyloid-positive patient identification

Barthélemy, Nicolas R., Bateman, Randall J., Hirtz, Christophe, Marin, Philippe, Becher, François, Sato, Chihiro, Gabelle, Audrey, Lehmann, Sylvain
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
12
Language:
english
Journal:
Alzheimer's Research & Therapy
DOI:
10.1186/s13195-020-00596-4
Date:
December, 2020
File:
PDF, 1.28 MB
english, 2020
Conversion to is in progress
Conversion to is failed